Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Vasculitis Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Vasculitis Drugmarket, defines the market attractiveness level of Vasculitis Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Vasculitis Drug industry, describes the types of Vasculitis Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Vasculitis Drug market and the development prospects and opportunities of Vasculitis Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Vasculitis Drug market in Chapter 13.
By Player:
Hainan Pharmaceutical Factory
Farmalider
Merck
Hubei Biocause Pharmaceutical
CSPC Ouyi Pharmaceutical
Bayer
Huzhou Konch Pharmaceutical
Sino-US Zibo Xinhua-Perrigo Pharmaceutical
Shanghaihuangxiang Lantian Pharmaceutical
By Type:
Blisibimod
CCX-168
Gevokizumab
Rituximab Biosimilar
Others
By End-User:
Polyarteritis Nodosa
Thrombotic Vasculitis
Granulomatous Vasculitis
Lymphocytic Vasculitis
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Vasculitis Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Vasculitis Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Vasculitis Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Vasculitis Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Vasculitis Drug Market Analysis and Outlook to 2022
-
7.1 Global Vasculitis Drug Consumption (2017-2022)
-
7.2 United States Vasculitis Drug Consumption (2017-2022)
-
7.3 Europe Vasculitis Drug Consumption (2017-2022)
-
7.4 China Vasculitis Drug Consumption (2017-2022)
-
7.5 Japan Vasculitis Drug Consumption (2017-2022)
-
7.6 India Vasculitis Drug Consumption (2017-2022)
-
7.7 South Korea Vasculitis Drug Consumption (2017-2022)
8 Region and Country-wise Vasculitis Drug Market Analysis and Outlook to 2028
-
8.1 Global Vasculitis Drug Consumption Forecast (2022-2028)
-
8.2 United States Vasculitis Drug Consumption Forecast (2022-2028)
-
8.3 Europe Vasculitis Drug Consumption Forecast (2022-2028)
-
8.4 China Vasculitis Drug Consumption Forecast (2022-2028)
-
8.5 Japan Vasculitis Drug Consumption Forecast (2022-2028)
-
8.6 India Vasculitis Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Vasculitis Drug Consumption Forecast (2022-2028)
9 Global Vasculitis Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Vasculitis Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Blisibimod Consumption and Growth Rate (2017-2022)
-
9.1.2 Global CCX-168 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Gevokizumab Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Rituximab Biosimilar Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Vasculitis Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Polyarteritis Nodosa Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Thrombotic Vasculitis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Granulomatous Vasculitis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Lymphocytic Vasculitis Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Vasculitis Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Vasculitis Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Blisibimod Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global CCX-168 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Gevokizumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Rituximab Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Vasculitis Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Polyarteritis Nodosa Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Thrombotic Vasculitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Granulomatous Vasculitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Lymphocytic Vasculitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Vasculitis Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Vasculitis Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Vasculitis Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Vasculitis Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Vasculitis Drug Market Competitive Analysis
-
14.1 Hainan Pharmaceutical Factory
-
14.1.1 Hainan Pharmaceutical Factory Company Details
-
14.1.2 Hainan Pharmaceutical Factory Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Hainan Pharmaceutical Factory Vasculitis Drug Product and Service
-
14.2 Farmalider
-
14.2.1 Farmalider Company Details
-
14.2.2 Farmalider Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Farmalider Vasculitis Drug Product and Service
-
14.3 Merck
-
14.3.1 Merck Company Details
-
14.3.2 Merck Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck Vasculitis Drug Product and Service
-
14.4 Hubei Biocause Pharmaceutical
-
14.4.1 Hubei Biocause Pharmaceutical Company Details
-
14.4.2 Hubei Biocause Pharmaceutical Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Hubei Biocause Pharmaceutical Vasculitis Drug Product and Service
-
14.5 CSPC Ouyi Pharmaceutical
-
14.5.1 CSPC Ouyi Pharmaceutical Company Details
-
14.5.2 CSPC Ouyi Pharmaceutical Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 CSPC Ouyi Pharmaceutical Vasculitis Drug Product and Service
-
14.6 Bayer
-
14.6.1 Bayer Company Details
-
14.6.2 Bayer Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bayer Vasculitis Drug Product and Service
-
14.7 Huzhou Konch Pharmaceutical
-
14.7.1 Huzhou Konch Pharmaceutical Company Details
-
14.7.2 Huzhou Konch Pharmaceutical Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Huzhou Konch Pharmaceutical Vasculitis Drug Product and Service
-
14.8 Sino-US Zibo Xinhua-Perrigo Pharmaceutical
-
14.8.1 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Company Details
-
14.8.2 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Product and Service
-
14.9 Shanghaihuangxiang Lantian Pharmaceutical
-
14.9.1 Shanghaihuangxiang Lantian Pharmaceutical Company Details
-
14.9.2 Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Vasculitis Drug
-
Figure Vasculitis Drug Picture
-
Table Global Vasculitis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Vasculitis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Vasculitis Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Vasculitis Drug Consumption by Country (2017-2022)
-
Figure United States Vasculitis Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Vasculitis Drug Consumption and Growth Rate (2017-2022)
-
Figure China Vasculitis Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Vasculitis Drug Consumption and Growth Rate (2017-2022)
-
Figure India Vasculitis Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Vasculitis Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Vasculitis Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Vasculitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Vasculitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Vasculitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Vasculitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Vasculitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Vasculitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blisibimod Consumption and Growth Rate (2017-2022)
-
Figure Global CCX-168 Consumption and Growth Rate (2017-2022)
-
Figure Global Gevokizumab Consumption and Growth Rate (2017-2022)
-
Figure Global Rituximab Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Polyarteritis Nodosa Consumption and Growth Rate (2017-2022)
-
Figure Global Thrombotic Vasculitis Consumption and Growth Rate (2017-2022)
-
Figure Global Granulomatous Vasculitis Consumption and Growth Rate (2017-2022)
-
Figure Global Lymphocytic Vasculitis Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Blisibimod Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CCX-168 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gevokizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rituximab Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Polyarteritis Nodosa Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Thrombotic Vasculitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Granulomatous Vasculitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lymphocytic Vasculitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Vasculitis Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Vasculitis Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Hainan Pharmaceutical Factory (Foundation Year, Company Profile and etc.)
-
Table Hainan Pharmaceutical Factory Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hainan Pharmaceutical Factory Vasculitis Drug Product and Service
-
Table Farmalider (Foundation Year, Company Profile and etc.)
-
Table Farmalider Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Farmalider Vasculitis Drug Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Vasculitis Drug Product and Service
-
Table Hubei Biocause Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Hubei Biocause Pharmaceutical Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hubei Biocause Pharmaceutical Vasculitis Drug Product and Service
-
Table CSPC Ouyi Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table CSPC Ouyi Pharmaceutical Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSPC Ouyi Pharmaceutical Vasculitis Drug Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Vasculitis Drug Product and Service
-
Table Huzhou Konch Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Huzhou Konch Pharmaceutical Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Huzhou Konch Pharmaceutical Vasculitis Drug Product and Service
-
Table Sino-US Zibo Xinhua-Perrigo Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Product and Service
-
Table Shanghaihuangxiang Lantian Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Product and Service
-
